• Featured Product
  • KD/KO验证

CoraLite® Plus 488-conjugated AMOT Polyclonal antibody

AMOT Polyclonal Antibody for IF/ICC
Cat No. CL488-24550

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IF/ICC

KIAA1071, Angiomotin

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  CoraLite® Plus 488
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inHEK-293 cells
For other applications, we recommend the unconjugated version of this antibody, 24550-1-AP

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL488-24550 targets AMOT in IF/ICC applications and shows reactivity with human samples.

经测试应用 IF/ICC Application Description
经测试反应性 human
免疫原 AMOT fusion protein Ag19784 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 angiomotin
别名 KIAA1071, Angiomotin
计算分子量 1084 aa, 118 kDa
观测分子量 80 kDa, 130 kDa
GenBank蛋白编号BC130294
基因名称 AMOT
Gene ID (NCBI) 154796
RRIDAB_3672768
偶联类型 CoraLite® Plus 488 Fluorescent Dye
最大激发/发射波长493 nm / 522 nm
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ4VCS5
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Angiomotin belongs to the motin family of angiostatin binding protein. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells during the formation of new blood vessels. Most abundant expression was found in placenta and skeletal muscle. AMOT has two isoforms with MW 130 kDa (p130) and 80 kDa (p80). The p130 isoform can interact with F-actin.This antibody recognizes both p130 and p80.

实验方案

Product Specific Protocols
IF protocol for CL Plus 488 AMOT antibody CL488-24550Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...